Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
In the semaglutide arm only, other non-prespecified baseline variables (age, ethnicity, diabetes status, sex, type of surgery, time since surgery (months), meal-stimulated change in GLP-1 at baseline, postoperative %WL (from DOS to randomization)) and maximum %WL achieved after surgery or MBS response (weight regain versus suboptimal post-surgery weight loss) were added to the primary outcome linear regression model for the semaglutide arm only (therefore omitting the treatment allocation covariate) to assess their relationship with %WL induced by semaglutide at 68 weeks
Some states require a prescription
It has been used for short-term weight management for over 60 years and typically produces results over 12 weeks
(November 18, 2021)
